Terms: = Uterine cancer AND ACVR1, SKR1, 90, ENSG00000115170, Q04771, ACVRLK2, FOP, ALK2, ACTRI AND Prognosis
433 results:
1. Endometrial cytological findings for a mesonephric-like endometrial adenocarcinoma: A case report.
Omine H; Ishida K; Sasaki N; Kato H; Nagai T; Ishikawa M; Takaoka M; Noda S; Matsuda H; Mitsuhashi A
Diagn Cytopathol; 2024 Jun; 52(6):E129-E133. PubMed ID: 38454318
[TBL] [Abstract] [Full Text] [Related]
2. The Role of Lymphovascular Space Invasion and Cytology in the prognosis of Endometrial cancer.
Ozdemir CY; Arioz DT; Celik F; Cicekli N; Chkhikvadze M; Bilir F; Yılmaz S; Vatansever N
Discov Med; 2024 Feb; 36(181):366-371. PubMed ID: 38409841
[TBL] [Abstract] [Full Text] [Related]
3. Raman spectroscopy combined with multivariate statistical algorithms for the simultaneous screening of cervical and breast cancers.
Cao Y; Xiong J; Du Y; Tang Y; Yin L
Lasers Med Sci; 2024 Feb; 39(1):68. PubMed ID: 38374512
[TBL] [Abstract] [Full Text] [Related]
4. Impact of histological subtypes on clinical outcome of endocervical adenocarcinoma.
Tian X; Liu P; Kang S; Cui Z; Sun L; Lang J; Chen C
Eur J Surg Oncol; 2024 Apr; 50(4):107977. PubMed ID: 38373385
[TBL] [Abstract] [Full Text] [Related]
5. Prognostic Impact of Heat Shock Protein 90 Expression in Women Diagnosed with Cervical cancer.
Vogelsang TLR; Schmoeckel E; Topalov NE; Ganster F; Mahner S; Jeschke U; Vattai A
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338850
[TBL] [Abstract] [Full Text] [Related]
6. Real-world outcomes of first-line maintenance therapy for recurrent or metastatic cervical cancer: A multi-center retrospective study.
Peng C; Li X; Tang W; Zhu W; Yan P; Chen J; Zhang X; Guo Q; Wu Q; Wang Q; Liu N; Ma A; Lu Y; Lv P; Liu J; Xie P
Int Immunopharmacol; 2024 Mar; 129():111578. PubMed ID: 38330795
[TBL] [Abstract] [Full Text] [Related]
7. Evaluation of the Antibacterial, Anti-Cervical cancer Capacity, and Biocompatibility of Different Graphene Oxides.
Castro JI; Payan-Valero A; Valencia-Llano CH; Insuasty D; Rodríguez Macias JD; Ordoñez A; Valencia Zapata ME; Mina Hernández JH; Grande-Tovar CD
Molecules; 2024 Jan; 29(2):. PubMed ID: 38257194
[TBL] [Abstract] [Full Text] [Related]
8. Associations of metformin therapy treatment with endometrial cancer risk and prognosis: A systematic review and meta-analysis.
Xie H; Li M; Zheng Y
Gynecol Oncol; 2024 Mar; 182():15-23. PubMed ID: 38246042
[TBL] [Abstract] [Full Text] [Related]
9. Targeting HER2-mutant metastatic cervical cancer with neratinib: Final results from the phase 2 SUMMIT basket trial.
Friedman CF; D'Souza A; Bello Roufai D; Tinker AV; de Miguel M; Gambardella V; Goldman J; Loi S; Melisko ME; Oaknin A; Spanggaard I; Shapiro GI; ElNaggar AC; Panni S; Ravichandran V; Frazier AL; DiPrimeo D; Eli LD; Solit DB
Gynecol Oncol; 2024 Feb; 181():162-169. PubMed ID: 38211393
[TBL] [Abstract] [Full Text] [Related]
10. [Effects of preoperative diagnostic hysteroscopy on peritoneal cytology and prognosis in patients with non-endometrioid carcinoma].
Zhai ZY; Yang L; Li H; Li LW; Shen ZH; Zhang XB; Wang ZQ; Wang JL
Zhonghua Fu Chan Ke Za Zhi; 2023 Dec; 58(12):903-910. PubMed ID: 38123196
[No Abstract] [Full Text] [Related]
11. Salvage radiotherapy strategy and its prognostic significance for patients with locoregional recurrent cervical cancer after radical hysterectomy: a multicenter retrospective 10-year analysis.
Shan M; Deng Y; Zou W; Fan S; Li Y; Liu X; Wang J
BMC Cancer; 2023 Sep; 23(1):905. PubMed ID: 37752476
[TBL] [Abstract] [Full Text] [Related]
12. Endometrial adenocarcinoma recurring in the lung: impact of molecular profile and role of local therapies on prognosis.
Luzarraga Aznar A; Bebia V; López-Gil C; Giraldo A; Montoya MP; Verges R; Jauregui A; Castellvi J; Pérez-Benavente A; Colás E; Gil-Moreno A; Cabrera S
Int J Gynecol Cancer; 2023 Oct; 33(10):1564-1571. PubMed ID: 37726197
[TBL] [Abstract] [Full Text] [Related]
13. Functional analysis reveals driver cooperativity and novel mechanisms in endometrial carcinogenesis.
Brown M; Leon A; Kedzierska K; Moore C; Belnoue-Davis HL; Flach S; Lydon JP; DeMayo FJ; Lewis A; Bosse T; Tomlinson I; Church DN
EMBO Mol Med; 2023 Oct; 15(10):e17094. PubMed ID: 37589076
[TBL] [Abstract] [Full Text] [Related]
14. Effects of hysteroscopic surgery combined with progesterone therapy on fertility and prognosis in patients with early endometrial cancer and atypical endometrial hyperplasia or endometrial intraepithelial neoplasia: a meta-analysis.
Ye X; Li T
Arch Gynecol Obstet; 2024 Jan; 309(1):259-268. PubMed ID: 37540307
[TBL] [Abstract] [Full Text] [Related]
15. The sarcopenia index measured using the lumbar paraspinal muscle is associated with prognosis in endometrial cancer.
Uno K; Yoshikawa N; Kitami K; Mori S; Shibata T; Iyoshi S; Fujimoto H; Mogi K; Yoshihara M; Tamauchi S; Ikeda Y; Yokoi A; Kato K; Hoshiba T; Oguchi H; Kajiyama H
Jpn J Clin Oncol; 2023 Oct; 53(10):942-949. PubMed ID: 37519058
[TBL] [Abstract] [Full Text] [Related]
16. Evaluation of somatic mutations in cervicovaginal samples as a non-invasive method for the detection and molecular classification of endometrial cancer.
Pelegrina B; Paytubi S; Marin F; Martínez JM; Carmona Á; Frias-Gomez J; Peremiquel-Trillas P; Dorca E; Zanca A; López-Querol M; Onieva I; Benavente Y; Barahona M; Fernandez-Gonzalez S; De Francisco J; Caño V; Vidal A; Pijuan L; Canet-Hermida J; Dueñas N; Brunet J; Pineda M; Matias-Guiu X; Ponce J; Bosch FX; De Sanjosé S; Alemany L; Costas L
EBioMedicine; 2023 Aug; 94():104716. PubMed ID: 37480623
[TBL] [Abstract] [Full Text] [Related]
17. Projected cancer burden, challenges, and barriers to cancer prevention and control activities in the state of Telangana.
Mahajan H; Reddy N; Devi NGM; Poli UR; Jayaram M; Tetali S; Murthy GVS;
PLoS One; 2023; 18(7):e0278357. PubMed ID: 37450553
[TBL] [Abstract] [Full Text] [Related]
18. Metabolic syndrome score as an indicator in a predictive nomogram for lymph node metastasis in endometrial cancer.
Feng X; Li XC; Yang X; Cheng Y; Dong YY; Wang JY; Zhou JY; Wang JL
BMC Cancer; 2023 Jul; 23(1):622. PubMed ID: 37403054
[TBL] [Abstract] [Full Text] [Related]
19. High DNA methylation age deceleration defines an aggressive phenotype with immunoexclusion environments in endometrial carcinoma.
Hao J; Liu T; Xiu Y; Yuan H; Xu D
Front Immunol; 2023; 14():1208223. PubMed ID: 37388735
[TBL] [Abstract] [Full Text] [Related]
20. Sarcoma Research with cancer Registry Data: Data and Peculiarities of Germany in the Light of Other Countries.
Zeissig SR; Emrich K; Reinwald F; Kasper B; Kleihues-van Tole K; Justenhoven C; Wardelmann E; Hohenberger P
Oncol Res Treat; 2023; 46(9):370-381. PubMed ID: 37379812
[TBL] [Abstract] [Full Text] [Related]
[Next]
